Abcam Plc (NASDAQ: ABCM)
Some price data may be temporarily unavailable.
Abcam Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Abcam Plc Company Info
Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.
News & Analysis
Why Shares of Abcam Are Jumping Friday
The company said it is looking at strategic alternatives, including a possible sale.
Why Shares in Abcam Surged This Week
An angry founder and an activist investor look set to shake things up at the life sciences company.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.